Proliferative Breast Disease With Atypia Atypical Hyperplasia and Precursor Lesions

Slide 1 · Adaptations of Cellular Growth

and Differentiation

HYPERPLASIA

Cell-number adaptation: physiologic responses, pathologic triggers, and clinical significance

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Define hyperplasia and separate it from hypertrophy.

Distinguish physiologic and pathologic proliferative responses.

Explain the major organ-specific examples.

Interpret stimulus dependence, reversibility, and cancer risk.

Slide 3 · Cellular adaptation changes tissue architecture

Under sustained demand or stimulation, living tissues can adjust cell size, cell number, or cell phenotype.

Hyperplasia specifically changes the number of cells.

Whether cells can divide constrains the available adaptation.

Hyperplasia is one adaptation—not a synonym for enlargement.

Slide 4 · Hyperplasia means more cells

Reference tissue

Hyperplasia: More cells

Schematic illustration — illustrative cell counts only; Not an observed specimen.

The defining observation is an increase in cell number within an organ or tissue.

Slide 5 · Stimulus → proliferation → increased cell number

Stimulus to susceptible tissue

Proliferative response

Additional cells in tissue

The initial signal may be hormonal, growth factor–mediated, compensatory, or viral.

The final effect is multiplication of cells capable of dividing.

Slide 6 · Cell division capacity is a prerequisite

Proliferatively competent

Limited ability to divide

Hyperplasia can occur

Hypertrophy may dominate

Conceptual diagram — response depends on the proliferative capacity of the target tissue.

Hyperplasia requires mature cells able to proliferate or a contribution from tissue stem cells.

Slide 7 · Hyperplasia and hypertrophy are distinct

Feature

Hyperplasia

Hypertrophy

Primary change

Cell number increases

Individual cell size increases

Requirement

Proliferative capacity

Cellular growth capacity

Common outcome

Increased tissue mass

Increased tissue mass

Can coexist?

Yes

Yes

An enlarged organ does not, by itself, identify which mechanism predominates.

Slide 8 · More cells versus larger cells

Hyperplasia

Hypertrophy

Schematic — cell quantity and size are contrasted independently.

The schematic contrasts an increased count of similarly sized cells with fewer enlarged cells.

Slide 9 · Hyperplasia and hypertrophy often coexist

Both changes can occur in the same tissue in response to a shared stimulus.

Physiologic enlargement of breast glandular epithelium illustrates combined cell multiplication and cell growth.

Precise terminology matters when explaining mechanisms of organ enlargement.

Slide 10 · What does organ enlargement prove?

Finding

Interpretation supported

Not established by itself

Increased organ mass

A growth response has occurred

Cell number or size contribution

More epithelial cells

Hyperplasia is present

The stimulus is physiologic

Larger individual cells

Hypertrophy is present

The tissue is neoplastic

Interpret the cellular basis before assigning a mechanistic label.

Slide 11 · Two broad contexts of hyperplasia

Increased demand or regulated stimulation

Physiologic hyperplasia

Appropriate, controlled tissue response

Pathologic hyperplasia instead reflects inappropriate or excessive growth-related stimulation.

Slide 12 · Physiologic versus pathologic hyperplasia

Dimension

Physiologic

Pathologic

Stimulus

Appropriate hormonal or compensatory

Excessive or inappropriate signaling

Illustrations

Breast, liver, bone marrow

Endometrium, prostate, warts

Biologic control

Regulated

Abnormal but often controlled

Clinical framing

Functional adaptation

May cause disease or carry risk

Slide 13 · Functional need is central to physiologic hyperplasia

Hormones and growth factors expand tissue capacity when greater functional output is required.

An appropriate compensatory response can follow injury or loss of organ mass.

These processes increase the number of responsive, proliferating cells.

Slide 14 · Hormonal hyperplasia: Signal and response

Physiologic hormone signal

Hormone-responsive target cells

More functional epithelium

Breast glandular epithelium responds during puberty and pregnancy.

Enlargement of epithelial cells may occur in parallel.

Slide 15 · Breast growth at puberty

Before stimulation

Hormone-responsive proliferation

Schematic glandular epithelial cell populations — not an anatomical breast section.

Breast glandular epithelium as a classic hormonal hyperplasia example.

Slide 16 · Breast changes in pregnancy

Before stimulation

Hormone-responsive proliferation

Schematic glandular epithelial cell populations — not an anatomical breast section.

Pregnancy provides another physiologic setting for expansion of breast glandular epithelium.

Slide 17 · Two contributions to breast enlargement

Response

Cellular event

Conceptual result

Hyperplasia

More glandular epithelial cells

More functional epithelial units

Hypertrophy

Larger glandular epithelial cells

More cellular mass per cell

The two mechanisms are complementary, not mutually exclusive.

Slide 18 · Compensatory hyperplasia follows tissue loss

Loss or resection of tissue

Regenerative proliferative signaling

Restoration of tissue mass

Compensation is a response to reduced organ capacity.

Liver regeneration is the classic example in the source.

Slide 19 · Liver donation illustrates regeneration

Liver before donation

Residual liver

Compensatory recovery

Schematic — proportional areas are illustrative, not measured liver volumes or recovery rates.

After donation of a liver lobe, the remaining liver increases in mass.

Slide 20 · Liver regrowth begins with surviving cells

Partial hepatectomy

Remaining viable liver cells

Proliferative expansion

Growth-factor–driven signaling in surviving liver cells is the proximate mechanism discussed in the adjacent section.

Slide 21 · Regeneration recovers organ mass

Baseline tissue mass

After resection

Regeneration

Schematic — proportional areas are illustrative, not measured liver volumes or recovery rates.

Compensatory proliferation can restore the liver toward its original size.

Slide 22 · Liver regeneration is a model of tissue control

The stimulus is removal of tissue rather than a tumor-associated autonomous program.

Residual organ cells expand after a reduction in functional mass.

Experimental partial hepatectomy models have informed understanding of regenerative signals.

Slide 23 · Bone marrow can rapidly expand production

Erythroid precursors

Increased red-cell production

Schematic — erythroid precursor expansion supports replacement of mature red cells.

Bone marrow shows robust physiologic proliferative capacity.

Slide 24 · Blood loss activates erythroid compensation

Acute bleeding

Deficit in circulating red cells

Increased erythroid production

Growth-factor feedback supports replacement of lost mature blood cells.

Slide 25 · Hemolysis is another erythroid stimulus

Premature red-cell destruction

Red-cell deficit

Expansion of red-cell progenitors

Hemolysis and bleeding differ in cause but converge on compensatory erythropoiesis.

Slide 26 · Erythropoietin links demand to production

Red-cell deficit

Erythropoietin feedback

Erythroid progenitor growth

Increased mature red-cell output

Feedback represented conceptually; No kinetic or concentration values are implied.

Feedback loops involving erythropoietin stimulate erythroid progenitor growth.

Slide 27 · Marrow response can be substantial

Up to

8×

Red-cell production

Magnitude explicitly reported for compensatory erythropoietic capacity.

Red-cell production may increase as much as eightfold in this compensatory setting.

Slide 28 · Three physiologic examples have different triggers

Tissue

Proximate need

Proliferating population

Breast

Hormonal/functional development

Glandular epithelial cells

Liver

Restoration after partial resection

Residual liver cells

Bone marrow

Replacement of deficient red cells

Erythroid progenitors

Slide 29 · Recognizing a physiologic adaptive response

Identify a biologically appropriate stimulus: Hormones, lost tissue, or missing mature cells.

Determine which cell population is expanding.

Relate the proliferation to enhanced or restored functional capacity.

Slide 30 · Pathologic hyperplasia is stimulus-driven growth

Most pathologic hyperplasias result from excessive or inappropriate hormone or growth-factor actions.

The cells remain responsive to growth regulation even though the stimulus is abnormal.

Hyperplasia can cause clinical symptoms and may provide a setting for subsequent genetic change.

Slide 31 · From an abnormal signal to tissue expansion

Excessive / inappropriate signal

Responsive target-cell proliferation

Pathologic hyperplastic tissue

The central abnormality in common examples is regulation of the proliferative signal—not necessarily loss of all control.

Slide 32 · Normal endometrium is hormonally responsive

Menstrual period

Estrogen-related proliferation

Progesterone restraint

Schematic hormonal phases — not a timed menstrual-cycle chart.

Endometrial epithelium normally undergoes a postmenstrual burst of proliferation.

Slide 33 · Estrogen promotes endometrial proliferation

Ovarian estrogen stimulation

Endometrial proliferative activity

Growth of endometrial glands

In normal cycles this growth is time-limited, rather than unchecked.

Slide 34 · Progesterone limits the proliferative phase

Rise in progesterone

Suppression of further proliferation

Cycle transitions beyond growth

A progesterone-associated halt in endometrial proliferation.

Slide 35 · Endometrial regulation depends on balance

Estrogen: Promotes proliferation

Progesterone: Limits proliferation

Cyclic endometrial growth depends on balanced regulation

Functional schematic — no hormone concentrations or diagnostic thresholds implied.

The relationship between estrogenic stimulation and progesterone-mediated restraint governs cyclic growth.

Slide 36 · Relative estrogen excess changes the outcome

Absolute or relative estrogen increase

Insufficient progesterone balance

Excess endometrial gland proliferation

Pathologic hyperplasia follows failure to maintain the usual hormonal balance.

Slide 37 · Endometrial glands become hyperplastic

Normal proliferative response

Hyperplastic glandular response

Schematic gland profiles; NOT H&E histology or diagnostic classification criteria.

The affected cell population is the endometrial glandular epithelium.

Slide 38 · Abnormal uterine bleeding is a key consequence

Endometrial hyperplasia is a common cause of abnormal uterine bleeding.

The clinical manifestation links an endocrine proliferative disturbance to an organ-level symptom.

The symptom alone does not specify the underlying tissue diagnosis.

Slide 39 · Normal proliferation versus pathologic glandular hyperplasia

Feature

Normal cyclical response

Pathologic hyperplasia

Hormonal setting

Timed, balanced stimulation

Absolute/relative estrogen predominance

Proliferation

Limited to an appropriate phase

Excess glandular cell production

Interpretation

Physiologic adaptation

Potential cause of abnormal bleeding

Slide 40 · Endometrial hyperplasia has longer-term significance

Increased cell division provides additional opportunities to acquire genetic abnormalities.

Endometrial hyperplasia as a setting associated with increased endometrial cancer risk.

This risk statement does not mean that an individual hyperplastic lesion is already cancer.

Slide 41 · Prostatic hyperplasia is another hormonal example

Androgen-related signal

Proliferative tissue response

Benign prostatic hyperplasia

Causal schematic — not a prostate histologic or anatomical section.

Benign prostatic hyperplasia is categorized as a pathologic hyperplastic response.

Slide 42 · Androgenic signaling underlies the prostatic example

Androgen-related stimulation

Prostatic target-cell response

Benign prostatic hyperplasia

The source uses BPH to illustrate inappropriate hormonal drive, not malignant autonomy.

Slide 43 · Endometrium and prostate: Parallel mechanisms

Example

Growth-related stimulus

Hyperplastic response

Endometrium

Estrogen predominance over progesterone restraint

Endometrial gland proliferation

Prostate

Androgenic stimulation

Benign prostatic hyperplasia

Both are pathologic examples but arise in different hormone-responsive tissues.

Slide 44 · Hormone-driven pathology may remain controlled

An abnormal stimulus does not automatically imply neoplasia.

That hormonal hyperplasias can stabilize or regress after the stimulus is removed.

Growth dependence is central to distinguishing adaptation from autonomous malignant proliferation.

Slide 45 · Withdrawal of stimulation changes tissue behavior

Remove growth-promoting stimulus

Reduced proliferative drive

Regression or stabilization

The source describes this possibility for the hormonal forms of pathologic hyperplasia.

Slide 46 · Regression and stabilization are different outcomes

Response

Meaning

Implication

Regression

Previously expanded tissue decreases

Growth response can be reversible

Stabilization

Tissue ceases to expand further

Growth has become limited

Neither outcome alone supplies a specific diagnosis or treatment protocol.

Slide 47 · Infection can also provoke hyperplasia

Certain viral infections elicit hyperplastic epithelial responses.

Papillomaviruses are the source’s principal viral example.

Hyperplastic masses may develop in skin and mucosal epithelium.

Slide 48 · Papillomavirus-associated warts

Control epithelium

Papillomavirus-associated hyperplasia

Schematic layers show increased cell numbers; NOT an authentic micrograph of a wart.

Cutaneous warts exemplify virus-associated epithelial hyperplasia.

Slide 49 · Viral factors perturb cell-cycle regulation

Papillomavirus infection

Viral factors affect host proliferation regulators

Expansion of infected epithelium

The essential mechanism is viral interference with host proteins controlling cell proliferation.

Slide 50 · Hyperplastic mucosal lesions may also be viral

The source identifies mucosal as well as cutaneous virus-induced lesions.

In both settings, the hallmark is excessive epithelial proliferation.

Some virus-driven proliferative lesions have precursor potential; The source does not assign a universal risk level.

Slide 51 · Hyperplasia is distinct from cancer

Aspect

Hyperplasia

Cancer

Central concept

Increased cell numbers in response to stimulus

Unrestrained proliferative behavior

Signal control

Often remains stimulus-responsive

Growth regulation is fundamentally altered

Relationship

May provide setting for evolution

Not equivalent to initial hyperplasia

This is a conceptual distinction, not a stand-alone histologic diagnostic test.

Slide 52 · Why repeated cell division matters for cancer risk

Increased rounds of cell division

Opportunity for genetic aberrations

Potential progression in susceptible settings

Elevated proliferative activity to increased opportunity for cancer-driving changes.

Progression is possible, not inevitable.

Slide 53 · Cancer risk is not the same as cancer

Hyperplastic proliferation

May remain regulated

More opportunities for genetic errors

Regression or stabilization

Potential neoplastic evolution

Possible pathways, not a deterministic or quantitative progression model.

Slide 54 · Keep three statements separate

Statement

Meaning

Teaching implication

Hyperplasia exists

Cell number has increased

Describe an adaptive/proliferative process

Hyperplasia is pathologic

Stimulus is excessive or inappropriate

Investigate cause and consequence

Cancer is present

Malignant neoplasia exists

Requires separate evidence

Slide 55 · Underlying mechanisms: A brief bridge

Growth factors engage receptors

Mature-cell proliferation

Sometimes stem-cell contribution

Receptor signaling and tissue stem-cell output in the next, separately indexed unit.

Slide 56 · Two sources of additional cells

Cell source

How tissue expands

Source example

Mature cells

Existing viable cells enter proliferation

Surviving liver cells after resection

Tissue stem cells

More descendant cells are generated

Compromised hepatocyte division in some liver injuries

An adjacent-section concept is included only to clarify the definition.

Slide 57 · Interpret hyperplasia at three levels

Stimulus: Is the increase physiologic demand or inappropriate signaling?

Cellular mechanism: Which proliferative population produces additional cells?

Clinical meaning: Is the result useful compensation, symptomatic growth, or a risk-bearing lesion?

Slide 58 · Clinical application: Pubertal breast development

Clinical stem

A patient undergoes normal breast development at puberty. Which cellular adaptation accounts for the increase in glandular epithelial cell number?

Interpretation

Physiologic hormonal hyperplasia.

Hormone-driven epithelial proliferation may coexist with hypertrophy.

Slide 59 · Clinical application: Liver donation

Clinical stem

A healthy adult donates a liver lobe. Over time, the residual organ recovers toward its previous mass. Which principle is demonstrated?

Interpretation

Compensatory hyperplasia and tissue regeneration.

Proliferation of remaining viable cells supports recovery after resection.

Slide 60 · Clinical application: Erythroid marrow

Clinical stem

After substantial blood loss, the marrow increases output of new erythrocytes. What links the peripheral deficit to precursor proliferation?

Interpretation

Erythropoietin-mediated feedback.

The signal stimulates expansion of erythroid progenitors and increased red-cell production.

Slide 61 · Clinical application: Abnormal uterine bleeding

Clinical stem

A patient with abnormal uterine bleeding has an endometrium exposed to sustained estrogenic predominance. Which adaptation is expected?

Interpretation

Pathologic endometrial glandular hyperplasia.

The essential source mechanism is excessive proliferative stimulation relative to progesterone restraint.

Slide 62 · Clinical application: Epithelial wart

Clinical stem

A skin wart shows epithelial accumulation following papillomavirus infection. Why can a viral lesion show hyperplasia?

Interpretation

Viral factors interfere with host proteins regulating cell proliferation.

Increased division builds a hyperplastic epithelial lesion; Cancer cannot be inferred merely from its presence.

Slide 63 · Clinical application: Prostatic enlargement

Clinical stem

A benign prostatic growth response is attributed to androgenic stimulation. Is “benign” incompatible with “pathologic hyperplasia”?

Interpretation

No. A growth response can be benign yet pathologic.

The classification depends on inappropriate stimulation, not automatic malignant behavior.

Slide 64 · Comparative synthesis across organs

Tissue

Driver

Interpretation

Breast

Appropriate hormones

Physiologic

Liver

Tissue resection

Compensatory

Bone marrow

Deficit of mature red cells

Compensatory

Endometrium

Estrogen predominance

Pathologic

Prostate

Androgen-related stimulus

Pathologic

Skin / mucosa

Papillomavirus

Virus-associated pathologic

Slide 65 · Hyperplasia: Essential pathology principles

Hyperplasia is a stimulus-associated increase in cell number in proliferatively competent tissue.

Physiologic forms serve functional or compensatory needs; Pathologic forms arise from inappropriate growth-related stimuli.

Abnormal hyperplastic growth often remains controlled, but increased cell division can create a setting for neoplastic evolution.

Slide 66 · Selected source and scope

Robbins, Cotran & Kumar: Pathologic Basis of Disease. 11th edition (2026). Chapter 2, pp. 53–54: Hyperplasia.

Chapter 2, p. 54: Mechanisms of Hyperplasia (adjacent context only).

Chapter 2, p. 56: Cellular Adaptations to Stress — key concepts.

Source material is confined to the general hyperplasia chapter section; detailed organ-specific criteria belong to their dedicated chapters.